Order Article Reprints

Genaro LM, Carron J, Lourenço GJ, Nagasako CK, Reis GFSR, Camargo MG, Oliveira PdSP, Lima CSP, Ayrizono MdLS, Azevedo ATd, et al. Interpretable Artificial Neural Network Models for Predicting Anti-Adalimumab Immune Complex and Serum Drug Level in Crohn’s Disease: A Proof-of-Concept Study. Pharmaceutics. 2025; 17(12):1536. https://doi.org/10.3390/pharmaceutics17121536

Genaro, Livia Moreira, Juliana Carron, Gustavo Jacob Lourenço, Cristiane Kibune Nagasako, Glaucia Fernanda Soares Rupert Reis, Michel Gardere Camargo, Priscilla de Sene Portel Oliveira, Carmen Silvia Passos Lima, Maria de Lourdes Setsuko Ayrizono, Anibal Tavares de Azevedo, and et al. 2025. "Interpretable Artificial Neural Network Models for Predicting Anti-Adalimumab Immune Complex and Serum Drug Level in Crohn’s Disease: A Proof-of-Concept Study" Pharmaceutics 17, no. 12: 1536. https://doi.org/10.3390/pharmaceutics17121536

Genaro, L. M., Carron, J., Lourenço, G. J., Nagasako, C. K., Reis, G. F. S. R., Camargo, M. G., Oliveira, P. d. S. P., Lima, C. S. P., Ayrizono, M. d. L. S., Azevedo, A. T. d., & Leal, R. F. (2025). Interpretable Artificial Neural Network Models for Predicting Anti-Adalimumab Immune Complex and Serum Drug Level in Crohn’s Disease: A Proof-of-Concept Study. Pharmaceutics, 17(12), 1536. https://doi.org/10.3390/pharmaceutics17121536